S

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Watchlist Manager
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Watchlist
Price: 18.56 CNY -0.48%
Market Cap: ¥12.3B

Gross Margin

31%
Current
Improving
by 2.2%
vs 3-y average of 28.8%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
31%
=
Gross Profit
¥1.4B
/
Revenue
¥4.5B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
31%
=
Gross Profit
¥1.4B
/
Revenue
¥4.5B

Peer Comparison

Country Company Market Cap Gross
Margin
CN
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
12.3B CNY
Loading...
JP
Hoya Corp
TSE:7741
9.8T JPY
Loading...
US
Medline Inc
NASDAQ:MDLN
62.6B USD
Loading...
CH
Alcon AG
SIX:ALC
30.7B CHF
Loading...
DK
Coloplast A/S
CSE:COLO B
97.7B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
13.6B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
JP
Asahi Intecc Co Ltd
TSE:7747
927.6B JPY
Loading...
KR
HLB Inc
KOSDAQ:028300
8.3T KRW
Loading...
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.4B USD
Loading...

Market Distribution

In line with most companies in China
Percentile
65th
Based on 8 314 companies
65th percentile
31%
Low
-2 148% — 14.3%
Typical Range
14.3% — 34.6%
High
34.6% — 775.2%
Distribution Statistics
China
Min -2 148%
30th Percentile 14.3%
Median 23%
70th Percentile 34.6%
Max 775.2%

Shandong Pharmaceutical Glass Co Ltd
Glance View

Market Cap
12.3B CNY
Industry
Health Care

In the vast landscape of China's industrial might lies Shandong Pharmaceutical Glass Co Ltd., a company serving as a key player in the healthcare and pharmaceutical sectors. Established in 1970, the company has developed a reputation as a leading manufacturer and supplier of pharmaceutical packaging, particularly glass containers. It specializes in producing molded glass and glass tubing that form the backbone of safe and reliable drug delivery systems, including ampoules, vials, and cartridges. Over the decades, Shandong Pharmaceutical Glass Co Ltd. has leveraged its expertise in glass manufacturing to meet stringent industry standards and cater to the ever-evolving needs of its clients, ranging from pharmaceutical giants to smaller biotech firms. At the heart of its business model, Shandong Pharmaceutical Glass generates revenue by providing essential packaging solutions that are integral to the pharmaceutical supply chain. The company's success hinges on its ability to innovate and produce high-quality, durable glass products that ensure the integrity and safety of medicinal products during storage, transportation, and administration. With the rising global demand for pharmaceuticals, particularly in Asia Pacific markets, Shandong Pharmaceutical Glass's focus on sustainable, efficient, and technologically advanced manufacturing processes positions it strategically to capitalize on growth opportunities. By embedding itself in the pharmaceutical lifecycle, the company not only safeguards medications but also fortifies its own standing in a rapidly expanding industry.

Intrinsic Value
26.34 CNY
Undervaluation 30%
Intrinsic Value
Price ¥18.56
S
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
31%
=
Gross Profit
¥1.4B
/
Revenue
¥4.5B
What is Shandong Pharmaceutical Glass Co Ltd's current Gross Margin?

The current Gross Margin for Shandong Pharmaceutical Glass Co Ltd is 31%, which is above its 3-year median of 28.8%.

How has Gross Margin changed over time?

Over the last 3 years, Shandong Pharmaceutical Glass Co Ltd’s Gross Margin has increased from 26.3% to 31%. During this period, it reached a low of 24.5% on Mar 31, 2023 and a high of 31.3% on Sep 30, 2025.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett